glp-1 medicaid Pennsylvania stopped covering GLP-1s for obesity this year, but it's not all savings More states consider dropping GLP-1
Description
From cravings to avoidance, here's what thousands of GLP-1 users are saying about how their relationship with food has changed.
GLP-1 drugs like Ozempic and Zepbound have gained significant attention for treating both diabetes and assisting with weight loss.
GLP-1RA medications are the first pharmacotherapy for obesity with demonstrable cardiovascular benefits and ASCVD risk reduction
Read the full article covered by Nutritional Outlook here:
As eating patterns become more consistent and hydration habits improve, many patients notice a steadier rhythm to their skin and overall energy
Learn what GLP-1 agonists and antagonists are and how they work
